Stay updated on Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check13 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision tag 'Revision: v3.7.0' was added to the history. The previous tag 'Revision: v3.6.6' appears to be removed as the latest entry.SummaryDifference0.0%

- Check55 days agoChange DetectedThe Record History now lists a new site revision, v3.6.6, as the latest update, replacing the previous v3.6.5.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s revision label was updated to Revision: v3.6.5, indicating a new build of the record history interface. This update is a metadata/technical change and does not alter the study information displayed.SummaryDifference0.0%

- Check91 days agoChange DetectedThe revision label was updated from v3.6.3 to v3.6.4, indicating a software version update reflected in the document history. This change represents an update to the page's versioning rather than study data or content.SummaryDifference0.0%

Stay in the know with updates to Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS p.G12C+ Solid Tumors Clinical Trial page.